Pre-order Enquiry
Request Free Sample
Global Olanzapine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
SKU ID : GIR-12534577 | Publishing Date : 07-Jun-2018 | No. of pages : 133
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
Scope of the Report:
This report focuses on the Olanzapine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2011, the Lilly’s patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years.
At present, the United States is the largest producer and consumer of the olanzapine. Almost all of the olanzapine are used for manufacturing the olanzapine tablets products, most of the olanzapine producers manufacture the olanzapine for self-use, only few for export. Lilly is the largest producer and dominants the high-end field. The rest of manufacturers manufactures the generic olanzapine products, facing the low-end market, like Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals and Zhejiang Langhua Pharmaceuticals etc. Canada India Israel and China play the important roles in the olanzapine market. But to the olanzapine tablets market, USA Japan and Europe are the most important consumers.
The worldwide market for Olanzapine is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 210 million US$ in 2023, from 180 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Patent Type
Generics Type
Market Segment by Applications, can be divided into
Olanzapine Tablets
Other Medicine
There are 15 Chapters to deeply display the global Olanzapine market.
Chapter 1, to describe Olanzapine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Olanzapine, with sales, revenue, and price of Olanzapine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Olanzapine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Olanzapine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Olanzapine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Olanzapine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2011, the Lilly’s patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years.
At present, the United States is the largest producer and consumer of the olanzapine. Almost all of the olanzapine are used for manufacturing the olanzapine tablets products, most of the olanzapine producers manufacture the olanzapine for self-use, only few for export. Lilly is the largest producer and dominants the high-end field. The rest of manufacturers manufactures the generic olanzapine products, facing the low-end market, like Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals and Zhejiang Langhua Pharmaceuticals etc. Canada India Israel and China play the important roles in the olanzapine market. But to the olanzapine tablets market, USA Japan and Europe are the most important consumers.
The worldwide market for Olanzapine is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 210 million US$ in 2023, from 180 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Patent Type
Generics Type
Market Segment by Applications, can be divided into
Olanzapine Tablets
Other Medicine
There are 15 Chapters to deeply display the global Olanzapine market.
Chapter 1, to describe Olanzapine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Olanzapine, with sales, revenue, and price of Olanzapine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Olanzapine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Olanzapine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Olanzapine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
